BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests

BERLIN, NIMES, France and RICHMOND, California - Diagnostics company BRAHMS Aktiengesellschaft, Cezanne and Lumiphore Inc., a biotechnology leader from California, announced that they have signed an agreement on incorporation of Lumiphore’s Lumi4(R)-Tb complexes in BRAHMS diagnostic tests.